MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02734cam a2200337 4500 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9241401036 |
| 035 ## - |
|---|
| -- |
(Sirsi) 9241401036 |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 268 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
910903s1991 1 0 eng |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Fiches modèles OMS d' information à l' usage des prescripteurs médicaments utilisés dans les mycobactérioses |
| 242 10 - TRANSLATION OF TITLE BY CATALOGING AGENCY |
|---|
| Title |
Modelo OMS de información sobre prescripción de medicamentos :medicamentos utilizados en las enfermedades micobacterianas |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
WHO model prescribing information : |
| Remainder of title |
drugs used in mycobacterial diseases. |
| 246 0# - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Drugs used in mycobacterial diseases |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Geneva : |
| Name of publisher, distributor, etc. |
World Health Organization, |
| Date of publication, distribution, etc. |
1991. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
40 p. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
chi published by : Beijing : Chinese Anti-Tuberculosis Association. |
| 520 3# - SUMMARY, ETC. |
|---|
| Summary, etc. |
Provides model prescribing information for some thirteen essential drugs used for the prevention and treatment of tuberculosis, for the treatment of leprosy, and for the treatment of diseases caused by nontuberculous mycobacteria, including localized cutaneous lesions, pulmonary disease, lymphadenitis, and disseminated disease. The first chapter, devoted to tuberculosis, opens with a detailed overview of the disease, its clinical features, and the main principles of prevention, tuberculin testing, and chemotherapy. The special problems of diagnosis and treatment in HIV-infected patients are briefly discussed. Readers are also given detailed information on the properties of antituberculosis drugs, preferred treatment regimens, monitoring of patient compliance and therapeutic response, and the treatment of relapsing and unresponsive disease. Against this background, model prescribing information is presented for ten drugs used in vaccination, chemoprophylaxis, and chemotherapy. Each drug is profiled in terms of its clinical uses, dosage and mode of administration, contraindications and precautions, use in pregnancy, adverse effects, and possible interactions with other drugs. Drugs used in the treatment of leprosy are covered in the second chapter, which also features background information on the disease and the main principles of multi-drug therapy. The final chapter provides prescribing information for drugs used to treat non-specific mycobacterial infections. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
chi eng fre spa. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
ben. |
| 550 ## - ISSUING BODY NOTE |
|---|
| Issuing body note |
WHODOC |
| 561 ## - OWNERSHIP AND CUSTODIAL HISTORY |
|---|
| History |
WHO monograph |
| 596 ## - |
|---|
| -- |
4 |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antitubercular agents. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Leprostatic agents. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Mycobacterium infections |
| General subdivision |
drug therapy. |
| 650 02 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Prescriptions, Drug. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Pharmaceuticals and Biologicals. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://apps.who.int/iris/">https://apps.who.int/iris/</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
NLM Classification Scheme |
| Koha item type |
Books |
